RT Journal Article
SR Electronic
T1 Risperidone is not only a prodrug: psychosis induced by medication switch from risperidone to paliperidone – a case report
JF European Journal of Hospital Pharmacy
JO Eur J Hosp Pharm
FD British Medical Journal Publishing Group
SP ejhpharm-2021-002901
DO 10.1136/ejhpharm-2021-002901
A1 Dagenais-Beaulé, Vincent
YR 2021
UL http://ejhp.bmj.com/content/early/2021/11/15/ejhpharm-2021-002901.abstract
AB Once administered, risperidone is converted into its pharmacologically active form, paliperidone. Thus, their pharmacological effects are expected to be equivalent. We encountered a psychosis induced by the switch from risperidone to paliperidone.This is the case of a schizoaffective patient stabilised on risperidone long-acting injection (LAI) who consented to switch to paliperidone LAI. On day 0, he received his first dose of paliperidone. On day 86, he presented to the emergency department with an acute psychotic episode. On day 92, he committed a violent act. The patient was restarted on risperidone LAI and stabilised.Risperidone is extensively metabolised to paliperidone via CYP450 2D6. Interindividual and ethnic genetic polymorphism cause variability in CYP450 2D6 phenotypes. In this possible case of low-functioning alleles, the patient had a higher risperidone to paliperidone ratio at steady state. Although risperidone is paliperidone’s prodrug, this case highlights the interindividual pharmacotherapeutic response to these two antipsychotics.All data relevant to the study are included in the article.